Cargando…

Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits

BACKGROUND: The COVID-19 disease frequently causes neurological symptoms. Critically ill patients often require neurorehabilitation for manifestations like intensive care unit (ICU) acquired weakness or encephalopathy. The outcome of these patients, however, is largely unknown. Here we report the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wimmer, Corinna, Egger, Marion, Bergmann, Jeannine, Huge, Volker, Müller, Friedemann, Jahn, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649895/
https://www.ncbi.nlm.nih.gov/pubmed/36388208
http://dx.doi.org/10.3389/fneur.2022.1012685
_version_ 1784827886565326848
author Wimmer, Corinna
Egger, Marion
Bergmann, Jeannine
Huge, Volker
Müller, Friedemann
Jahn, Klaus
author_facet Wimmer, Corinna
Egger, Marion
Bergmann, Jeannine
Huge, Volker
Müller, Friedemann
Jahn, Klaus
author_sort Wimmer, Corinna
collection PubMed
description BACKGROUND: The COVID-19 disease frequently causes neurological symptoms. Critically ill patients often require neurorehabilitation for manifestations like intensive care unit (ICU) acquired weakness or encephalopathy. The outcome of these patients, however, is largely unknown. Here we report the clinical course of critical affected COVID-19 patients from hospital admission to discharge from inpatient neurorehabilitation. METHODS: Prospective cohort study. COVID-19 patients admitted to neurorehabilitation were included based on a laboratory-confirmed SARS-CoV-2 infection. Assessments [modified Rankin Scale (mRS), Barthel-Index, Fatigue-Severity-Scale-7 and health-related quality of life (EQ-5D-5L)] were conducted at admission and before discharge from inpatient care. Data were compared to the preclinical health status. RESULTS: Sixty-one patients (62 ± 13 years, 16 female) were included in the analysis. Most patients had been treated on ICU (n = 58; 57 ± 23 days) and had received invasive ventilation (n = 57; 46 ± 21 days). After discharge from ICU, patients spent on average 57 ± 26 days in neurorehabilitation. The most frequent neurological diagnoses were ICU-acquired weakness (n = 56) and encephalopathy (n = 23). During rehabilitation overall disability improved [mRS median (IQR) 4.0 (1.0) at inclusion and 2.0 (1.0) at discharge]. However, the preclinical health state [mRS 0.0 (0.0)] was not regained (p < 0.001). This was also reflected by the Barthel-Index [preclinical 100.0 (0.0), at inclusion 42.5 (35.0), at discharge 65.0 (7.5); p < 0.001]. Patients had only minor fatigue during inpatient care. Quality of life generally improved but was still low at discharge from hospital. CONCLUSION: Patients with neurological sequelae after critical COVID-19 disease showed substantial deficits at discharge from inpatient care up to 4 months after the initial infection. They were restricted in activities of daily living and had reduced health-related quality of life. All patients needed continued medical support and physical treatment.
format Online
Article
Text
id pubmed-9649895
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96498952022-11-15 Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits Wimmer, Corinna Egger, Marion Bergmann, Jeannine Huge, Volker Müller, Friedemann Jahn, Klaus Front Neurol Neurology BACKGROUND: The COVID-19 disease frequently causes neurological symptoms. Critically ill patients often require neurorehabilitation for manifestations like intensive care unit (ICU) acquired weakness or encephalopathy. The outcome of these patients, however, is largely unknown. Here we report the clinical course of critical affected COVID-19 patients from hospital admission to discharge from inpatient neurorehabilitation. METHODS: Prospective cohort study. COVID-19 patients admitted to neurorehabilitation were included based on a laboratory-confirmed SARS-CoV-2 infection. Assessments [modified Rankin Scale (mRS), Barthel-Index, Fatigue-Severity-Scale-7 and health-related quality of life (EQ-5D-5L)] were conducted at admission and before discharge from inpatient care. Data were compared to the preclinical health status. RESULTS: Sixty-one patients (62 ± 13 years, 16 female) were included in the analysis. Most patients had been treated on ICU (n = 58; 57 ± 23 days) and had received invasive ventilation (n = 57; 46 ± 21 days). After discharge from ICU, patients spent on average 57 ± 26 days in neurorehabilitation. The most frequent neurological diagnoses were ICU-acquired weakness (n = 56) and encephalopathy (n = 23). During rehabilitation overall disability improved [mRS median (IQR) 4.0 (1.0) at inclusion and 2.0 (1.0) at discharge]. However, the preclinical health state [mRS 0.0 (0.0)] was not regained (p < 0.001). This was also reflected by the Barthel-Index [preclinical 100.0 (0.0), at inclusion 42.5 (35.0), at discharge 65.0 (7.5); p < 0.001]. Patients had only minor fatigue during inpatient care. Quality of life generally improved but was still low at discharge from hospital. CONCLUSION: Patients with neurological sequelae after critical COVID-19 disease showed substantial deficits at discharge from inpatient care up to 4 months after the initial infection. They were restricted in activities of daily living and had reduced health-related quality of life. All patients needed continued medical support and physical treatment. Frontiers Media S.A. 2022-10-28 /pmc/articles/PMC9649895/ /pubmed/36388208 http://dx.doi.org/10.3389/fneur.2022.1012685 Text en Copyright © 2022 Wimmer, Egger, Bergmann, Huge, Müller and Jahn. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Wimmer, Corinna
Egger, Marion
Bergmann, Jeannine
Huge, Volker
Müller, Friedemann
Jahn, Klaus
Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits
title Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits
title_full Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits
title_fullStr Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits
title_full_unstemmed Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits
title_short Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits
title_sort critical covid-19 disease: clinical course and rehabilitation of neurological deficits
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649895/
https://www.ncbi.nlm.nih.gov/pubmed/36388208
http://dx.doi.org/10.3389/fneur.2022.1012685
work_keys_str_mv AT wimmercorinna criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits
AT eggermarion criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits
AT bergmannjeannine criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits
AT hugevolker criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits
AT mullerfriedemann criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits
AT jahnklaus criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits